A significant number of COVID-19 neurological complications— such as fatigue, headache, and cognitive impairment—are ultimately reversible, according to new research summarized by the Journal of Nuclear Medicine. The ...
Mar 17, 2022
0
101
A novel radionuclide drug tackles the challenge of prostate cancer imaging and takes a turn as a cancer-killing therapy for tumors in and out of the prostate, according to research presented during the 2015 Annual Meeting ...
Jun 8, 2015
0
212
In a new review of imaging studies spanning more than ten years, scientists find that a method of positron emission tomography (PET) safely and accurately detects dementia, including the most common and devastating form among ...
Jan 6, 2012
0
0
Preliminary research presented at SNM's 58th Annual Meeting is breaking new ground for the development of a brand new hybrid molecular imaging system. Simultaneous positron emission tomography (PET) and magnetic resonance ...
Jun 6, 2011
0
0
The origin of cancer is often obscured by metastases—tumors that have already spread to other tissues. This is especially the case for neuroendocrine tumors (NETs), a malignancy of nerve cells scattered throughout various ...
Jun 8, 2015
0
58
The featured clinical investigation article of the March 2017 issue of the Journal of Nuclear Medicine demonstrates that the PET radiotracer fluciclovine (fluorine-18; F-18) can help guide and monitor targeted treatment for ...
Mar 6, 2017
0
159
A study presented at SNM's 58th Annual Meeting may provide a new tool for detection of malignant-stage ovarian cancer. Researchers found that positron emission tomography and computed tomography (PET/CT), which images both ...
Jun 6, 2011
0
0
Bone scans have been found to overstage prostate cancer at initial staging compared to prostate-specific membrane antigen (PSMA) PET, according to new research published in the November issue of the Journal of Nuclear Medicine. ...
Nov 9, 2023
0
2
A new 225Ac-DOTA-based pre-targeted radioimmunotherapy (PRIT) system has been shown to cure a highly lethal form of advanced intraperitoneal ovarian cancer in a preclinical setting with minimal side effects. Targeting the ...
Sep 18, 2023
0
23
Prostate cancer is the leading cancer among men, second only to skin cancer. With surgical removal at the frontline of defense, oncologists are considering prostate-specific molecular imaging at the point of initial biopsy ...
Jun 15, 2016
0
3
